The effect of chemotherapy combined with recombination mutant human tumor necrosis factor on advanced cancer

Journal of Translational Medicine

Volumn 2, Issue , 2004, Pages

  Liu, Xing ^a   Zhang, Xiang Fu ^a   Zheng, Zhi Weng ^a   Lu, Huishan ^a   Wu, Xinyuan ^a   Huang, Changmin ^a   Wang, Chuan ^a   Guang, Guoxiang ^a  

^a FUJIAN MEDICAL UNIVERSITY   (China)

Author keywords

Biological therapy; Chemotherapy; Complex therapy; Tumor; Tumor necrosis factor

Indexed keywords

CISPLATIN; CYCLOPHOSPHAMIDE; DOXORUBICIN; FLUOROURACIL; INDOMETACIN; MITOMYCIN C; RECOMBINANT TUMOR NECROSIS FACTOR;

ADULT; ADVANCED CANCER; ANEMIA; ARTICLE; BONE PAIN; CANCER CHEMOTHERAPY; CANCER PATIENT; CHILL; CLINICAL TRIAL; COLORECTAL CANCER; COMMON COLD; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; DISEASE SEVERITY; DRUG EFFICACY; DRUG RESPONSE; FATIGUE; FEMALE; FEVER; HUMAN; HYPOTENSION; INJECTION PAIN; INJECTION SITE REACTION; LEUKOPENIA; LIVER DYSFUNCTION; LUNG HEMORRHAGE; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; MYALGIA; NAUSEA; PHASE 2 CLINICAL TRIAL; PHASE 3 CLINICAL TRIAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; STATISTICAL ANALYSIS; STOMACH CANCER; TREATMENT PLANNING; VOMITING;

EID: 18144388750     PISSN: 14795876     EISSN: 14795876     Source Type: Journal    
DOI: 10.1186/1479-5876-2-33     Document Type: Article

References (12)

1. Xian-Zhong Gao, Shu-Xu Xu: Current diagnosis and therapy of tumors [M]. Beijing, Science and Technology Press; 1973:118.
2. Min-Li Huang, Hong Sun, You-ji Feng, et al.: The study of Tumor-Necrosis Factor and chemotherapy on Gynecologic Carcinoma. Chin J Cancer Biother 1995, 2(3):202.
3. Lee KY, Chang W, Qiu D, et al.: PG 490 (triptolide) cooperates with tumors necrosis factor alpha to induce apoptosis in tumor cells[J]. J Biol Chem 1999, 274(19):13451-13455.
4. Lasek W, Giermasz A, Kuc K, et al.: Potentiation of the antitumor effect of actinomycin D by tumor necrosis factor alpha in mice: correlation between in vitro and vivo results[J]. Int J Cancer 1996, 66(3):374-379.
5. Libutti SK, Barlett DJ, Franker DL, et al.: Technique and results of hyperthermic isolated hepatic perfusion with tumor necrosis factor and melphalan for the treatment of unresectable hepatic malignancies[J]. J Am Coll Surg 2000, 191(5): 519-530.
6. Nakamura S, Kato A, Masegi T, et al.: A novel recombinant tumor necrosis factor alpha mutant with increased anti-tumor activity and lower toxicity[J]. Int J Cancer 1991, 48(5): 744-748.
7. Kamijo R, Takeda K, Nagumo M, et al.: Induction of differentiation of human monoblastic and myeloblastic leukemia cell lines by TNF muteins[J]. Biochem Biophys Res Commun 1989, 160(2): 820-827.
8. Zhang ying-qi, Zhao ning, Li bo, et al.: Preparation of a novel recombinant human tumor necrosis factor-α by gene engineering technology[J]. Chin J Cell Mol Immunol 2002, 18(4): 402-405.
9. Yi Su, Ya-Mei Wu: The study of synergistic cytotoxicity of tumor necrosis factor and interleukin-2 against lung adenocarcinoma cell[J]. Chinese Journal of Cancer 2000, 19(8):779-781.
10. Liddil JD, Dorr RT: Schedule dependent toxicity of tumor ecrosis factor in rodents. Cancer drug Deliv 1987, 4(3): 159-167.
11. Budd GT, Green S, Baker LH, et al.: A Southwest Oncology Group phase H trial of recombinant tumor necrosis factor in metastatic breast cancer. Cancer1991, 68(8):1694-1695.
12. Schilling PJ, Murray JL, Markowitz AB: Novel tumor necrosis factor toxic effects. Cancer 1992, 69:256-260.